To be eligible for this study, patients must meet several criteria, including but not limited to the following:
- Patients must have metastatic breast cancer that continues to grow despite at least two regimens of systemic therapy for advanced disease.
- Patients must have recovered from the serious side effects of prior therapies.
- Patients must be able to be ambulatory for more than half of their normal waking hours.
- Patients must be age 18 or older.
For more information about this study and to inquire about eligibility, please contact Dr. Tiffany A. Traina at 646-888-5209.